Champlain Investment Partners, LLC Idexx Laboratories Inc Transaction History

Champlain Investment Partners, LLC

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 13, 2024	SELL	$515.08 - $576.87 $55 Million - $61.6 Million	-106,725 Reduced 53.11%	94,221 $50.9 Million
Q4 2023 Feb 13, 2024	SELL	$391.37 - $557.56 $4.68 Million - $6.67 Million	-11,963 Reduced 5.62%	200,946 $112 Million
Q3 2023 Nov 13, 2023	SELL	$432.42 - $556.67 $196,751 - $253,284	-455 Reduced 0.21%	212,909 $93.1 Million
Q2 2023 Aug 11, 2023	SELL	$450.7 - $503.61 $112,675 - $125,902	-250 Reduced 0.12%	213,364 $107 Million
Q1 2023 May 12, 2023	SELL	$406.01 - $514.59 $1.74 Million - $2.21 Million	-4,295 Reduced 1.97%	213,614 $107 Million
Q4 2022 Feb 13, 2023	SELL	$324.64 - $441.27 $1.67 Million - $2.26 Million	-5,130 Reduced 2.3%	217,909 $88.9 Million
Q3 2022 Nov 14, 2022	BUY	$325.8 - $407.78 $23.7 Million - $29.7 Million	72,740 Added 48.4%	223,039 $72.7 Million
Q2 2022 Aug 12, 2022	BUY	$327.37 - $553.44 $49.2 Million - $83.2 Million	150,299 New	150,299 $52.7 Million

1,212

72.6M

167K

343K

Ticker IDXX
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 83,253,696
Market Cap $34.4B
Description
IDEXX Laboratories, Inc. develops, manufactures, and distributes products and services primarily for the companion animal veterinary, livestock and poultry, dairy, and water testing markets worldwide. The company operates through CAG; Water Quality Products; LPD; and Other segments. It provides point-of-care veterinary diagnostic products, inclu...

Get notified when there are updates to the investment portfolio of Champlain Investment Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Champlain Investment Partners, LLC with notifications on news.